OmniaBio Inc., a contract development and manufacturing organisation (CDMO) specialising in cell and gene therapy (CGT), has announced the opening of its new manufacturing and AI centre of excellence in Hamilton, Ontario. The facility is now the largest of its
Somite Therapeutics, a tech-bio company specialising in AI-driven cell replacement therapies, has announced a collaboration with OmniaBio Inc., a CDMO focused on cell and gene therapies, to produce its flagship program for Duchenne muscular dystrophy (DMD). The partnership centres on
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
